Champions Oncology, Inc. (CSBR): Price and Financial Metrics

Champions Oncology, Inc. (CSBR): $4.52

0.11 (-2.38%)

POWR Rating

Component Grades








Add CSBR to Watchlist
Sign Up

Industry: Biotech




#16 of 494

in industry

CSBR Price/Volume Stats

Current price $4.52 52-week high $7.32
Prev. close $4.63 52-week low $4.50
Day low $4.50 Volume 3,640
Day high $4.77 Avg. volume 7,092
50-day MA $4.99 Dividend yield N/A
200-day MA $5.66 Market Cap 61.44M

CSBR Stock Price Chart Interactive Chart >

Champions Oncology, Inc. (CSBR) Company Bio

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, the company provides POS products, including TumorGraft implants and drug panels, which utilizes TumorGraft technology to test the response of a patient's tumor to multiple oncology drugs or drug combinations. It markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

CSBR Latest News Stream

Event/Time News Detail
Loading, please wait...

CSBR Latest Social Stream

Loading social stream, please wait...

View Full CSBR Social Stream

Latest CSBR News From Around the Web

Below are the latest news stories about CHAMPIONS ONCOLOGY INC that investors may wish to consider to help them evaluate CSBR as an investment opportunity.

Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript December 12, 2023 Champions Oncology, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.17. Operator: Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note, this conference […]

Yahoo | December 14, 2023

CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024

CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

InvestorPlace Earnings on InvestorPlace | December 13, 2023

Champions Oncology Reports Quarterly Revenue of $11.6 Million

HACKENSACK, NJ / ACCESSWIRE / December 12, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its second ...

Yahoo | December 12, 2023

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

HACKENSACK, NJ / ACCESSWIRE / December 4, 2023 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the second ...

Yahoo | December 4, 2023

The past three years for Champions Oncology (NASDAQ:CSBR) investors has not been profitable

The truth is that if you invest for long enough, you're going to end up with some losing stocks. Long term Champions...

Yahoo | November 15, 2023

Read More 'CSBR' Stories Here

CSBR Price Returns

1-mo -10.14%
3-mo -20.42%
6-mo N/A
1-year -11.37%
3-year -55.16%
5-year -54.34%
YTD -19.57%
2023 24.61%
2022 -46.05%
2021 -22.52%
2020 29.53%
2019 6.66%

Continue Researching CSBR

Want to see what other sources are saying about Champions Oncology Inc's financials and stock price? Try the links below:

Champions Oncology Inc (CSBR) Stock Price | Nasdaq
Champions Oncology Inc (CSBR) Stock Quote, History and News - Yahoo Finance
Champions Oncology Inc (CSBR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!